Blood Sample Collection
Blood Sample Collection is an intervention with 137 clinical trials. Currently 37 active trials ongoing. Historical success rate of 86.7%.
Success Metrics
Based on 52 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
3
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.9%
52 of 62 finished
16.1%
10 ended early
37
trials recruiting
137
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients
Clinical and BIOgical Analyses of RECtal Tumors
A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury
Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
Clinical Trials (137)
A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients
Clinical and BIOgical Analyses of RECtal Tumors
A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury
Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
Guardant Shield Colorectal Cancer Screening
Study of a Polygenic Risk Score to Predict the Risk of Pancreatic Ductal Adenocarcinoma
Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
Mpox Biology, Outcome, Transmission and Epidemiology - Tracking the Immune Response After mpoX vaCcination (MBOTE-TRAXX): Clinical Study to Monitor the Immunological Response Following Mpox Vaccination in the City of Kinshasa, Democratic Republic of the Congo
Natural History Study for Patients With Nemaline Myopathy in Belgium
Enabling Genomic Testing in Cancer of Unknown Primary
CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung
Phenotypic Characterization Tumor-infiltrating Lymphocytes at Diagnosis and After Chemotherapy in Ovarian Cancer
Prospective Study to Assess a Diagnostic Aid for Cancer
Detecting HPV DNA in Anal and Cervical Cancers
Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
Pathophysiology of Dysautonomia and Postural Tachycardia Syndrome (POTS) in Post-viral Syndromes and COVID-19
Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
Study on the Association Between Vitamin C Deficiency and Diarrhea in Children
Immune Response and Risk of Serious Infection to SARS-Cov2
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 137